GDF11 and metabolic dysfunction-associated steatotic liver disease: demonstrated a considerably positive correlation between GDF11 mRNA levels and expression of genes that participated in NAFLD progression like peroxisome proliferator‐activated receptor gamma (PPARγ) and carnitine palmitoyl transferase 1 (CPT1).12